Page last updated: 2024-08-26

phorbolol myristate acetate and Hematologic Neoplasms

phorbolol myristate acetate has been researched along with Hematologic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ibrahim, S; Levin, B; Meruelo, D; Pellicer, A; Suzme, R; Tseng, JC1

Other Studies

1 other study(ies) available for phorbolol myristate acetate and Hematologic Neoplasms

ArticleYear
Sindbis viral vectors target hematopoietic malignant cells.
    Cancer gene therapy, 2012, Volume: 19, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Female; Gene Expression Regulation, Neoplastic; Genetic Therapy; Genetic Vectors; Hematologic Neoplasms; Humans; Injections, Intraperitoneal; Jurkat Cells; Male; Mice; Mice, Inbred AKR; Mice, Inbred C3H; Mice, Transgenic; Neoplasm Metastasis; Neoplasms, Experimental; Oncolytic Virotherapy; Receptors, Laminin; Sindbis Virus; Tetradecanoylphorbol Acetate

2012